Annual report [Section 13 and 15(d), not S-K Item 405]

Summary of Stock Options Activity (Details)

v3.26.1
Summary of Stock Options Activity (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]    
Number of Shares, Beginning Balance 603  
Weighted Average Exercise Price, Beginning Balance $ 4,902.19  
Weighted Average Grant Date Fair Value, Beginning $ 4,595.20  
Weighted Average Remaining Contractual Term (Years), Ending 9 years 10 months 20 days 6 years 11 months 23 days
Aggregate Intrinsic Value, Beginning Balance  
Number of Shares, Granted 102,250  
Weighted Average Exercise Price, Granted $ 18.32  
Weighted Average Grant Date Fair Value, Granted $ 6.69  
Weighted Average Remaining Contractual Term (Years), Granted 9 years 10 months 20 days  
Number of Shares, Exercised  
Weighted Average Exercise Price, Exercised  
Weighted Average Grant Date Fair Value, Exercised  
Number of Shares, Forfeited (34)  
Weighted Average Exercise Price, Forfeited $ 2,430.00  
Weighted Average Grant Date Fair Value, Forfeited $ 2,310  
Weighted Average Remaining Contractual Term (Years), Forfeited 7 years 8 months 8 days  
Number of Shares, Canceled/Expired (2,459)  
Weighted Average Exercise Price, Canceled/Expired $ 440.04  
Weighted Average Grant Date Fair Value, Canceled/Expired $ 417.08  
Weighted Average Remaining Contractual Term (Years), Canceled/Expired 9 years 1 month 20 days  
Number of Shares, Ending Balance 100,360 603
Weighted Average Exercise Price, Ending Balance $ 36.52 $ 4,902.19
Weighted Average Grant Date Fair Value, Ending $ 23.42 $ 4,595.20
Aggregate Intrinsic Value, Ending Balance
Number of Shares, Exercisable 100,360  
Weighted Average Grant Date Fair Value, Exercisable $ 36.52  
Weighted Average Exercise Price, Exercisable $ 23.42  
Weighted Average Remaining Contractual Term (Years), Exercisable 9 years 10 months 20 days  
Aggregate Intrinsic Value, Exercisable